TAKING STOCK
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Shire Pharmaceuticals advanced 6p to 247p after an upbeat progress report on its treatment for patients with mild to moderate Alzheimer's disease. The news came in the interim results of a major ongoing Phase II study presented at a key international meeting in Japan. Shire also reported "significant progress" by all its other businesses since flotation in February.
Data Systems International was requoted 17p lower at 138p after its reverse takeover of Standard Platforms, the loss-making document imaging group. DSI, which trades as Action Computer Supplies, intends to concentrate on selling information technology products through mail order and recently signed a pounds 5m deal with local authorities worth about 5 per cent of annual turnover.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments